Rationale: The lung extracellular matrix (ECM) in idiopathic pulmonary fibrosis (IPF) mediates progression of fibrosis by decreasing fibroblast expression of miR-29 (microRNA-29), a master negative regulator of ECM production. The molecular mechanism is undefined. IPF-ECM is stiffer than normal. Stiffness drives fibroblast ECM production in a YAP (yes-associated protein)-dependent manner, and YAP is a known regulator of miR-29. Therefore, we tested the hypothesis that negative regulation of miR-29 by IPF-ECM was mediated by mechanotransduction of stiffness.
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive form of lung scarring. Available data indicate that IPF lung extracellular matrix (ECM) itself is fibrogenic (1-3). Fibroblasts cultured on decellularized IPF lung ECM (IPF-ECM) suppresses expression of miR-29 (microRNA-29) (a master negative regulator of stromal genes), leading to increased ribosome recruitment to hundreds of stromal genes, including: collagens, fibronectin, and their cognate integrins; matrix metalloproteinases; and proteins controlling proliferation and motility. Restoration of fibroblast miR-29 expression returns translation of miR-29 target genes back to baseline (3) . Although miR-29 suppression has been established in IPF (4) and other fibrotic disorders (5-8) for several years; the underlying mechanisms remain unknown. Here we set out to unveil the molecular mechanism by which IPF-ECM decreases fibroblast miR-29 expression.
Identifying the ECM properties sensed by fibroblasts to suppress miR-29 has the potential to unveil new targets that can be exploited to develop therapies that interrupt fibrosis progression. One signature property of IPF lung ECM that distinguishes it from normal is its elastic modulus (stiffness). IPF lung ECM is up to an order of magnitude stiffer than normal, with steep stiffness gradients between fibrotic and morphologically uninvolved regions of the lung (1, 9) . Mechanotransduction of ECM stiffness has prominent roles in pathological processes, including cancer progression and fibrosis (9) (10) (11) (12) . Expression of the mechanosensitive Hippo pathway constituent YAP (yes-associated protein) is increased in the IPF lung, and ectopic expression of activated YAP confers fibroblasts with fibrogenic properties, including increased ECM production (9) . YAP has dual functions with diametric effects on miR-29 expression. At the singlegene level, YAP serves as a transcriptional coactivator of miR-29b-1/a (13), the gene encoding miR-29a and miR-29b-1; two of the three molecular species of miR-29 (a separate gene on chromosome 1 encodes miR-29b-2 [identical to miR-29b-1, together designated miR-29b] and miR29c). In contrast, on a genome-wide level, YAP functions as a negative regulator of microRNA expression by sequestering p72, an integral component of the microRNA processing machinery (14) . Thus, mechanotransduction of ECM stiffness leading to activation of YAP provides a plausible molecular mechanism by which IPF-ECM regulates miR-29.
To explore this possibility, we combined in situ analysis of IPF lung tissue with experiments using primary human lung fibroblasts studied on decellularized human lung ECM, ECM functionalized hydrogels of tunable stiffness, and two xenograft models. Although stiff hydrogels triggered fibroblast YAP activation and increased miR-29 expression, decellularized IPF-ECM did exactly the opposite, excluding mechanotransduction of stiffness through YAP as the primary mechanism. Instead, we discovered that IPF-ECM suppresses microRNA biogenesis at the processing step by downregulating Dicer1 (an integral microRNA processing component) in the myofibroblast core of the fibroblastic focus, where active ECM synthesis is taking place. Dicer1 deficiency in primary lung fibroblasts decreased mature miR-29 levels and increased *** (microRNA-29) expression and upregulates collagen production. Lung fibroblasts were cultured on control or IPF-ECM for 18 hours. (A) Mature miR-29a, -29b, and -29c values were quantified by quantitative PCR (qPCR) and normalized to RNU6 (n = 1 cell line). Shown is a box-and-whisker plot representing the mean of three technical replicates for the three species of miR-29 with the values for control (Ctrl)-ECM set to 1. (B) qPCR for Col4a2 and Col6a2 normalized to GAPDH (n = 2, representative experiment shown), and P value was calculated using the Student's two-tailed t test. (C) Medium was removed and equal volumes of serum-free medium were added to each reaction. After 8 hours, the conditioned medium was collected and equal volumes analyzed by immunoblot for type I collagen (n = 5 cell lines, densitometry values shown in graph below). Error bars represent mean 6 SD. P value was calculated using the Student's two-tailed t test for A and B, and paired two-tailed t test for C. *P , 0.05, **P , 0.01, ***P , 0.005. 
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Methods
Detailed methods can be found in the online supplement.
Statistical Analysis
For analyses of data with sample sizes greater than six, one-sample or two-sample t tests were used for hypothesis testing on the means of the distributions. 
Results
IPF-ECM Suppresses miR-29 Expression and Upregulates Collagen Production
Prior work using atomic force microscopy indicates that regions of the IPF-ECM are up to an order of magnitude stiffer than control-ECM (Ctrl-ECM) (1) . To interrogate the ECM at a scale approximating the size of the human lung acinus (3 mm 3 10 mm 3 5 mm), we quantified uniaxial tensile strain in lung tissue strips and found IPF-ECM to be significantly stiffer than Ctrl-ECM at this scale of resolution (see Figure  E1 in the online supplement 1C ; Figure E3 ).
Stiffness Increases miR-29 Expression on Two-Dimensional Hydrogels
To determine whether stiffness and/or composition could account for the suppression of miR-29 expression on IPF-ECM, we cultured lung fibroblasts on synthetic two-dimensional (2D) polyacrylamide hydrogels (PA gels) of physiological stiffness (soft PA gels z3 kPa) or IPF stiffness (stiff PA gels z20 kPa). To validate our model system, we analyzed the impact of stiffness on a-smooth muscle actin expression. In accord with published data (9, 16), lung fibroblasts displayed increased a-smooth muscle actin on stiff Primary lung fibroblasts were cultured for 24 hours in survival medium on gels mimicking physiological stiffness (3 kPa; soft polyacrylamide gels) or gels mimicking idiopathic pulmonary fibrosis stiffness (20 kPa; stiff polyacrylamide gels). Gels were functionalized with either: (A) type I collagen (n = 3 cell lines); (B) type III collagen (n = 3 cell lines); (C) fibronectin (n = 3 cell lines); or (D) an equal ratio of type I collagen, type III collagen, and fibronectin (n = 6 cell lines). Shown is a box-and-whisker plot of the mean quantitative PCR values on stiff hydrogels compared with soft (set to 1) for miR-29a, -29b, and -29c (normalized to RNU6 expression). P values were calculated using the Student's paired twotailed t test. *P , 0.05, **P , 0.01, ***P , 0.001.
PA gels functionalized with type I collagen ( Figure E4 ). We next examined the effect of stiffness on miR-29 expression and were surprised to find that fibroblast miR-29 expression was increased by stiff PA gels functionalized with type I collagen, pointing away from stiffness per se as the property of IPF-ECM downregulating miR-29 ( Figure 2A ). The PA gel system is versatile, as it allows the gels to be functionalized by coating with any ECM protein (17) . To test the relative importance of stiffness versus composition in regulating miR-29, we supplemented the collagen I data by coating PA gels with collagen III alone, fibronectin alone, or an equal ratio of collagen I, collagen III, and fibronectin. Independent of substratum composition, stiffness consistently upregulated mature miR-29 abundance ( Figures 2B-2D ), revealing the primacy of stiffness over composition in the 2D hydrogel model.
IPF-ECM Negatively Regulates YAP and Suppresses miR-29 Transcription
We next sought to determine whether there was a causal role for YAP in the regulation of miR-29 by IPF-ECM. In accord with prior work (9), when fibroblasts resided on stiff 2D hydrogels, YAP nuclear localization (active YAP) and two canonical YAP transcriptional targets, which serve as readouts of YAP function, all increased ( Figure E5 ). Contrary to expectation, when Fibroblasts transfected with an miR-29b-1/a firefly luciferase reporter were cultured for 24 hours on ECM, and luciferase activity was quantified (normalized to Renilla luciferase; n = 7 cell lines shown as a box-and-whisker plot, mean value shown normalized to Ctrl-ECM [set to 1]). Error bars represent mean 6 SD. P values were calculated using the Student's paired two-tailed t test. *P , 0.05.
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lung fibroblasts were cultured on IPF-ECM, YAP nuclear localization was reduced (inactive YAP) ( Figure 3A) , along with reduced expression of YAP transcriptional targets ( Figure 3B ). Although YAP mRNA abundance is not influenced by ECM type (3), IPF-ECM significantly decreased YAP protein levels ( Figure 3C ). YAP downregulation by IPF-ECM is in accord with a possible mechanistic relationship between YAP and one of its transcriptional targets, the gene encoding miR-29b-1/a (13). To examine this possibility, we introduced an miR-29b-1/a luciferase reporter (18) into lung fibroblasts and found that IPF-ECM caused a modest but significant suppression of miR-29b-1/a transcriptional activity ( Figure 3D ). This raised the possibility that fibroblast YAP deficiency on IPF-ECM might lead to decreased transcription of miR-29b-1/a. Figure 4A ). As evidence that we achieved YAP gain of function in both cases, YAP transcriptional targets, including primary-precursor (Pri-Pre) miR-29a, were all upregulated on IPF-ECM ( Figures 4B and 4C) . As a control, we examined the impact of YAP gain of function on miR-29b-2/c, which does not contain a YAP-responsive regulatory element (18) , and found its transcript abundance to be decreased-an effect that may represent an indirect effect of YAP gain of function. Despite increases in Pri-Pre miR-29a, mature miR-29 species remained unchanged after YAP gain of function ( Figure 4D ). YAP knockdown in lung fibroblasts on Ctrl-ECM had no effect ( Figure E6 ). Thus, the inability of YAP gain of function to rescue mature miR-29 expression in fibroblasts on IPF-ECM, despite increasing the levels of its primary/precursor forms, pointed downstream to deregulation of miR-29 processing as a candidate mechanism by which IPF-ECM suppresses miR-29.
IPF-ECM Suppresses the MicroRNA Processing Machinery
Processing of microRNA occurs cotranscriptionally, and processing of primary microRNA into precursor microRNA is a better predictor of mature microRNA abundance than transcriptional regulation alone (20) . Prior work using mouse fibroblasts indicates that miR-29 expression depends on Drosha, Exportin-5, and Dicer1 (21), key components of the canonical microRNA processing machinery ( Figure 5A ). Of note, Ago2 (Argonaute-2), another component of the microRNA processing pathway, is reduced in IPF (22) .
To determine whether IPF-ECM altered microRNA processing, we measured Pri-Pre and mature miR-29a and -29c abundance (representing the two miR-29 genes) on ECM ( Figure 5B ). PriPre miR-29 abundance increased on IPF-ECM, strongly implicating a downstream block in microRNA processing, particularly in view of the decreased transcription observed for miR29b-1/a on IPF-ECM. We therefore sought to determine whether IPF-ECM regulated Dicer1, Ago2, Drosha, or Exportin-5. IPF-ECM suppressed steady-state levels of Ago2, Drosha, and Dicer1, whereas Exportin-5 levels did not consistently change ( Figure 5C , Figure E7) . As a control, we examined the expression of three noncanonically processed microRNAs on IPF-ECM. Among the three (miR-320a, -451, and -484) (21), two of the three noncanonically processed microRNAs were unaltered by ECM type ( Figure E8 ). As a control for internal consistency, we found that fibroblast expression of Dicer1 and other components of the microRNA processing machinery did not differ between soft and stiff polyacrylamide gels ( Figure E9 ). Taken together, our experiments identified a microRNA processing defect as central to the suppression of fibroblast miR-29 expression by IPF-ECM.
Dicer1 Expression Is Reduced in Cells Comprising the Myofibroblast-Rich Core of the Fibroblastic Focus
Our experiments show that deregulation of lung fibroblast miR-29 expression Primary-precursor miR-29a and -29c were quantified by qPCR normalized to GAPDH; (D) mature miR-29a, -29b, and -29c were quantified by qPCR normalized to RNU6 (n = 2, representative experiment shown).
Error bars represent means 6 SD for B and C, and a box-and-whisker plot is shown for D. P value was calculated using a one-way ANOVA test followed by a Tukey test. *P , 0.001, **P , 0.0001.
on IPF-ECM results from defects in microRNA processing. However, the microRNA processing machinery is a complex multicomponent apparatus, precluding efficient gain-and loss-offunction experiments involving each component singly or in combination. To direct our search for the microRNA processing step underlying the in vivo biology in IPF, we analyzed expression of microRNA processing components in the myofibroblast-rich core of the fibroblastic focus in IPF specimens (23) . We analyzed serial sections for: histology (hematoxylin and eosin), procollagen I (a nascent form of collagen I and an miR-29 target), Ago2, Dicer1, Exportin-5, and Drosha. We consistently found that the myofibroblast-rich core of fibroblastic foci (defined by procollagen I reactivity) was deficient in Dicer1 compared with the focus perimeter and surrounding adjacent regions, whereas we found no consistent differences in Ago2, Exportin-5, or Drosha (n = 7 IPF specimens; Figure E10 ). Guided by this initial analysis, we serially sectioned IPF specimens to further explore Dicer1 expression at both the protein and RNA level. Serial sections (four tissue sections from one patient, 4 mm each) were analyzed for morphology ( Figure 6A ), procollagen I ( Figure 6B ), Dicer1 protein ( Figure 6C ), and Dicer1 mRNA (in situ hybridization by RNAscope; Figure 6D ). We examined a region of active collagen synthesis within the myofibroblast-rich focus core (dashed outlined box) and the focus perimeter (solid outlined box) with higher magnification (Figures 6B-6D , middle and right panels). The cells within the myofibroblast-rich core of the fibroblastic focus showed lower expression of both Dicer1 protein and mRNA (visualized as discrete brown dots) than cells at the focus perimeter. We quantified Dicer1 mRNA expression in six IPF lung specimens by enumerating the number of dots per cell within the myofibroblast-rich core compared with the focus perimeter ( Figure 6E ). Cells within the myofibroblastrich core had significantly lower levels of Dicer1 mRNA expression than cells at the focus perimeter (Poisson regression, P , 0.0001). Taken together, our data implicate a deficiency of Dicer1 in the myofibroblastrich core region of the fibroblastic focus where active collagen synthesis is taking place (on the basis of procollagen I expression) in the in vivo mechanism of the IPF-ECMmediated microRNA processing defect.
IPF-ECM Increases the Association of the Dicer1 Transcript with the RNABinding Protein AUF1
Available published literature points to control of Dicer1 mRNA levels by the RNAbinding protein AUF1 (AU-binding factor 1) (24) . AUF1 binds to AU-rich elements in the Dicer1 transcript and recruits the mRNA degradation machinery, leading to decreased steady-state levels of the transcript. If this mechanism is operating in IPF, then the association of AUF1 with the Dicer1 transcript should increase on IPF-ECM. To test this possibility, we cultured primary human lung fibroblasts on IPFand control-ECM and quantified AUF1 binding to Dicer1 mRNA through RNA immunoprecipitation ( Figure 7) . Consistent with this hypothesis, IPF-ECM increased the association of AUF1 with Dicer1 mRNA more than fivefold compared with control-ECM (P , 0.05 one-sided MannWhitney U test). Data are shown as a box-and-whisker plot, and P value was calculated using the Student's paired t test. *P , 0.05, **P , 0.0001. (C) Fibroblasts were cultured on ECM for 24 hours. Shown are immunoblots for Dicer1, Ago2, Drosha, Exportin-5, and GAPDH (n = 1 cell line).
Dicer1 Knockdown Decreases Mature miR-29 Abundance and Increases Expression of miR-29 Target Genes on Ctrl-ECM
If Dicer1 deficiency is central to the mechanism leading to reduced miR-29 levels in IPF, then decreasing Dicer1 levels in lung fibroblasts on Ctrl-ECM should replicate the biology observed on IPF-ECM. Stable Dicer1 knockdown in lung fibroblasts was achieved by transducing cells with a lentiviral-based shRNA ( Figure 8A ). In accord with a causal role, Dicer1 suppression decreased miR-29 abundance in lung fibroblasts on Ctrl-ECM (normalized to miR-451, which is processed independently of Dicer1) (21) (Figure 8B ), leading to increased secretion of miR-29 target genes ( Figure 8C ). We independently replicated this result in a second lung fibroblast line ( Figure E11 ). To test whether restoring Dicer1 would rescue fibroblast miR-29 expression on IPF-ECM, we attempted to overexpress Dicer1 in two primary fibroblast lines (and in a lung cancer line A549 as a nonfibroblast control); however, in each case, all cells detached from the substratum and showed morphological evidence of toxicity within 48 hours after gene delivery. This precluded analysis of fibroblast Dicer1 gain of function on IPF-ECM. These data identify decreased Dicer1 processing of precursor forms of miR-29 in the mechanism by which IPF-ECM decreases fibroblast miR-29 expression.
Dicer1 Knockdown Imparts Fibroblasts with Fibrogenicity In Vivo
Having shown that Dicer1 deficiency in primary human lung fibroblasts is sufficient to decrease all three species of miR-29 and increase ECM synthesis in vitro, we next sought to determine whether these same Dicer1-deficient fibroblasts would display increased ECM production in vivo in the absence of any other cues. We considered using a lung fibroblast-specific conditional Dicer1 knockout (KO) mouse model for this purpose but chose not to use this model on the basis of two considerations. First, the effect of Dicer1 KO in mouse lung fibroblasts may not be comparable to Dicer1 deficiency in primary human lung fibroblasts, which could differ profoundly from those in mouse cells when modeling cell-autonomous functions (25) . Second, studies in cancer using Dicer1 KO mice show that the Dicer1-null state inhibits tumor formation, a cell-autonomous function, whereas Dicer1 haploinsufficiency is permissive (26, 27) . Therefore, we took a direct approach to test whether Dicer1-deficient primary human lung fibroblasts would display cell intrinsic/autonomous fibrogenicity using two in vivo xenograft model systems specifically designed for this purpose.
We previously described the use of zebrafish embryos as a simple and rapid in vivo xenograft system for assessing lung fibroblast fibrogenicity (28, 29) . In control xenografts injected with fibroblasts transduced with nonsilencing scrambled shRNA, there were scattered procollagen I-expressing cells at the periphery of the graft, with only sparse procollagen I expression in the graft core ( Figure 9A ). In contrast, xenografts injected with fibroblasts transduced with Dicer1 shRNA (Dicer1-KD) displayed prominent procollagen I expression throughout ( Figure 9B ). Quantification by image analysis indicated a significant increase in human procollagen I expression in xenografts containing Dicer1-KD fibroblasts compared with those with nonsilencing scrambled shRNA control ( Figure 9C ).
As an independent assessment of in vivo fibrogenicity, we tested Dicer1-KD fibroblasts in a mouse tail vein injection xenograft model. In this model, IPF lung fibroblasts produce prominent angiocentric fibrotic lesions, whereas control lung fibroblasts do not (28, 30) . The lungs of mice receiving fibroblasts transduced with nonsilencing scrambled shRNA (n = 8) produced no morphological lesions ( Figure 9D , left panels), a result consistent with our prior report using unaltered primary lung fibroblasts (28). In sharp contrast, the lungs from four out of eight mice injected with Dicer1-KD fibroblasts developed fibrotic lesions (P , 0.04), similar in morphology to those formed by IPF lung fibroblasts (28) ( Figure 8D , middle and right panels). The largest of these fibrotic lesions spanned 300 mm at the 13-day time point (Figure E12 ). Thus, Dicer1 deficiency-even in the absence of cues from a fibrotic ECM-is sufficient to confer human lung fibroblasts with cellautonomous fibrogenicity in two in vivo xenograft models.
Discussion
Here we show that IPF-ECM inhibits lung fibroblast miR-29 expression upstream at the level of transcription and downstream at the processing step by suppressing Dicer1. Dicer1 deficiency suppresses lung fibroblast miR-29 expression on control ECM and confers lung fibroblasts with cell-autonomous fibrogenicity in vivo. We provide strong validation for our findings by showing that the cells in the myofibroblast-rich core of the IPF fibroblastic focus, where active collagen synthesis is taking place, display reduced levels of Dicer1 compared with cells comprising the focus perimeter. These data identify Dicer1 deficiency as a critical missing step in the mechanism of the IPF-ECM-driven profibrotic feedback loop, providing a new pathway to exploit for stopping fibrosis progression.
Several pathways can regulate miR-29 expression (7); however, we began our studies on the basis of the prevailing hypothesis in the field that ECM stiffness transduced through YAP could explain miR-29 deficiency in IPF. This concept derived from studies showing that stiffness drives lung fibroblast ECM production in a YAP-dependent manner on hydrogels (9) , that stiff IPF-ECM drives fibroblast ECM production by deregulation of miR-29 (3), and that YAP regulates miR-29 expression (13) and microRNA processing (14) , establishing a mechanistic link. When we compared fibroblast YAP and miR-29 expression on soft versus stiff hydrogels (a 2D system) to YAP and miR-29 expression on Ctrl-ECM versus IPF-ECM (a 3D system), stiff 2D hydrogels activated YAP and increased miR-29 levels, whereas IPF-ECM inactivated YAP and decreased miR-29 levels. This excluded stiffness as the primary property of IPF-ECM transduced by fibroblasts to deregulate YAP and miR-29.
Although these results were unexpected, they point to other ECM and cell surface properties that might play a role. These include dimensionality, viscoelasticity, cell-cell interactions, and Quantitative PCR for mature miR-29a, -29b, and -29c normalized to miR-451. Data are shown as a box-and-whisker plot, and P value was calculated using the Student's two-tailed t test. (C) Equal volumes of conditioned medium were analyzed by immunoblot for collagen I and MMP-2 (n = 2, representative experiment shown in triplicate). Densitometry values are shown in the lower panel, with error bars representing the SD, and P value was calculated using the Student's two-tailed t test. *P , 0.01, **P , 0.001, ***P , 0.0001. KD = knockdown. mRNA was normalized to immunoprecipitated GAPDH mRNA levels (a highly abundant transcript to control for nonspecific associations). Dicer1/GAPDH expression levels are displayed relative to the isotype control (IgG) precipitation from the corresponding ECM type. Error bars represent SD, and P value was calculated using a one-sided Mann-Whitney U test. *P = 0.05. cyclic stretch. In experiments examining mesenchymal stromal cell (MSC) YAP expression in response to substratum dimensionality (31) , stiffness drove YAP activation in a 2D system; whereas stiffness inactivated YAP in a 3D system. This result is in accord with our data, which showed fibroblast YAP activation on stiff 2D gels but YAP inactivation on IPF-ECM. In addition, independent of substratum stiffness or dimensionality, MSC YAP activation is driven by increased viscoelasticity (32, 33), a parameter not yet assessed in the IPF lung. As an additional consideration, the YAP response to MSC mechanosensing of matrix stiffness is dampened by an order of magnitude when MSC N-cadherin (mimicking cell-cell interactions) is ligated (34) . It is also worth noting that the constant strain and relaxation of the lungs during respiration represent a potentially important set of forces. Mammary epithelial cells activate YAP in response to cyclic stretch (35) , and cyclic stretch and compression in periodontal ligament cells regulate miR-29 and downstream gene expression (36) . Together, these studies illustrate the complexity of the mechanosensingmechanotransduction axis, highlighting a critical gap in our understanding of fibrosis progression in IPF.
Dicer1 can act as both a tumor suppressor and oncogene (37) . Global microRNA deregulation due to a microRNA processing defect is an established theme in cancer (38) and has been implicated in IPF (22, 39) . In accord with Dicer1 haploinsufficiency supporting cell autonomy in cancer, we found that experimentally induced Dicer1 deficiency in human lung fibroblasts decreased miR-29 abundance, increased collagen production, and supported cell-autonomous fibrogenicity in zebrafish and mouse xenografts. Thus, both cancer and IPF exploit decreases but not ablation of the terminal steps in microRNA processing to stabilize cell-autonomous pathology. Another emerging function of Dicer1 is its role in DNA damage repair (26, 40) , which we speculate might play a dual role in IPF progression. Recent data indicate that cellular senescence markers are expressed within the fibroblastic focus (41), and there is extensive crosstalk between DNA damage repair and cellular senescence (42) . Thus, our study provides strong support for the concept that the IPF fibroblastic focus is highly polarized, with Dicer1 deficiency restricted to the myofibroblast-rich core of the fibroblastic focus functioning as a driver of fibrosis progression.
The mechanisms regulating Dicer1 expression remain incompletely defined. Our data support a role for the RNA binding protein AUF1, which associates with the Figure 8 ) were xenografted into each zebrafish embryo, which was incubated for 46 hours, anesthetized, and fixed before analysis. Representative xenograft images of (A) scrambled control or (B) Dicer1-KD fibroblasts immunostained for human procollagen I (red) counterstained with DAPI (graft DAPI-positive area outlined by dotted white line, scale bar represents 50 mm, asterisk indicates sectioning artifact: a yolk granule with autofluorescence). (C) A Fire LUT was applied using ImageJ to the unaltered images to quantify relative procollagen fluorescence, corrected to a background uninvolved area from the same image. Shown is a box-and-whisker plot of relative procollagen fluorescence with P values calculated using the Wilcoxon sum-rank test (n = 13 scrambled control and n = 11 Dicer1-KD zebrafish xenografts, P = 0.0011). (D) Mouse xenograft assay: 10 6 scrambled control or Dicer1-KD fibroblasts (cells from the same population of lung fibroblasts used in Figure 8 ) were injected by tail vein into mice and lungs were harvested after 6 and 13 days (n = 4 scrambled control and n = 4 Dicer1-KD per time point for a total of 16 mice). P value was calculated using Fisher exact test (P = 0.04). Trichrome and procollagen I immunostain (red arrows mark human fibroblasts) identify fibrotic lesions (scale bar represents 50 mm for 6-day time point, or 200 mm for 13-day time point). the RNA degradation machinery (24) . We found that IPF-ECM increases binding of AUF1 to the Dicer1 transcript more than fivefold, providing an explanation for some of the decrease in Dicer1 transcript we observed. Another possible mechanism is suggested by studies relating cell density to microRNA processing; nuclear YAP was necessary for processing precursor microRNAs into their mature forms (43) . The microRNA Let-7, however, did not follow this trend. In the absence of nuclear YAP, Let-7 accumulates and targets Dicer1 mRNA (which contains Let-7 target sites), leading to a reduction in Dicer1 levels and defective microRNA processing. This is relevant because Let-7 levels are altered in IPF lung tissue (39) . However, the focus of studies to date has been whole lung tissue, and it remains to be determined whether Let-7 is increased within the procollagen I rich focus core where Dicer1 levels are low.
Although the underlying ECM properties that generate and maintain the polarity of the fibroblastic focus are not defined, one approach to elucidating this information would be to develop a comprehensive tissue atlas that combines mechanical measurements with cell identity and cell biology region by region. Although on average the IPF lung is stiffer than control, and there are some regional data available using atomic force microscopy, there are no data in IPF in which ECM mechanical properties (static and dynamic), topography, and chemistry have been coregistered to cell type and cell biology. Such data have proved highly informative in cancer biology (44) . Given the spatial heterogeneity of the fibrotic process in IPF, the importance of mechanotransduction in regulating cellular functions relevant to fibrosis, and the striking polarity of the fibroblastic focus, we conclude that studies connecting mechanics to cell biology region by region will be important to understand the molecular basis for fibrosis progression in IPF. n Author disclosures are available with the text of this article at www.atsjournals.org.
